Notice for International Patients & Caregivers

English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.

Provincial Landscape
Snapshot: 2026-10-21

Beijing Multiple Myeloma Active Trials & Centers

As of 2026-10-21, there are 44 active clinical trials for multiple myeloma hosted across 27 tertiary medical centers in Beijing (including Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Chao-Yang Hospital, Capital Medical University, Peking University First Hospital, etc.).

Active Trials
44
Hospitals
27
Therapies
CAR-T Cell Therapy / Bispecific & Multispecific Antibodies / Monoclonal Antibodies / Oral Small-Molecule Agents

Participating Medical Centers (27)

Peking Union Medical College Hospital, Chinese Academy of Medical SciencesBeijing Chao-Yang Hospital, Capital Medical UniversityPeking University First HospitalPeking University People's HospitalPeking University Third HospitalBeijing Gobroad HospitalBeijing Chaoyang Hospital (West Campus), Capital Medical UniversityXuanwu Hospital, Capital Medical UniversityCancer Hospital, Chinese Academy of Medical SciencesBeijing Jishuitan HospitalBeijing Boren HospitalBeijing Tongren Hospital, Capital Medical UniversityBeijing Chao-Yang Hospital, Capital Medical University (East Campus)Beijing Chao-Yang Hospital, Capital Medical University (West Campus)Fuxing Hospital, Capital Medical UniversityBeijing Gobroad Boren HospitalBeijing Jishuitan Hospital, Capital Medical UniversityBeijing Tongren HospitalThe Fifth Medical Center of the PLA General HospitalPeking University Cancer HospitalChinese PLA General Hospital (301 Hospital)Beijing Chaoyang HospitalChina-Japan Friendship HospitalBeijing Shijitan Hospital, Capital Medical UniversityPeking Union Medical College HospitalBeijing Chaoyang Hospital, Capital Medical UniversityBeijing Hospital

Active Studies in Beijing (44)

Population synthesized by CMDN

Showing 0 published English records of 44 registry trials.

All 44 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.